Intravenous Streptokinase versus Heparin in Recent Acute Myocardial Infarction

Intravenous streptokinase clearly confers a protective effect against early mortality in patients with suspected acute anterior myocardial infarction. The magnitude of this effect is on the order of a 5% absolute reduction in risk of death by 21 to 35 days. For these patients, 21 need to be treated to save 1 additional life. For patients with suspected acute inferior infarction, the benefit of treatment on reducing early mortality is of smaller magnitude and less certain. These patients have an estimated absolute reduction of early mortality of approximately 1%, which would require treating 125 patients to save 1 additional life.

show abstract

Effect of Intravenous Streptokinase on Early Mortality in Patients with Suspected Acute Myocardial Infarction

Midgette

O’Connor²,

Baron

et al. 1990

Ann Intern Med

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Intravenous Streptokinase versus Heparin in Recent Acute Myocardial Infarction

Cited by 1 publication

References 12 publications

Effect of Intravenous Streptokinase on Early Mortality in Patients with Suspected Acute Myocardial Infarction

Effect of Intravenous Streptokinase on Early Mortality in Patients with Suspected Acute Myocardial Infarction

Contact Info

Product

Resources

About